prepandemic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted) novartis vaccines and diagnostics
novartis vaccines and diagnostics s.r.l. - influenssa virus pinta-antigeenejä (haemagglutinin ja neuraminidaasin) kanta a, vietnam, 1194, 2004 (h5n1) - influenza, human; immunization; disease outbreaks - rokotteet - aktiivinen immunisaatio influenssa a -viruksen h5n1-alatyypin suhteen. , , this indication is based on immunogenicity data from healthy subjects from the age of 18 years onwards following administration of two doses of the vaccine containing a/vietnam/1194/2004 (h5n1)-like strain. , , prepandemic influenza vaccine (h5n1) novartis vaccines and diagnostic should be used in accordance with official recommendations.
zobuxa vet 15 mg tabletti
novartis healthcare a/s animal health - enrofloxacinum - tabletti - 15 mg - enrofloksasiini
zobuxa vet 50 mg tabletti
novartis healthcare a/s animal health - enrofloxacinum - tabletti - 50 mg - enrofloksasiini
zobuxa vet 100 mg tabletti
novartis healthcare a/s animal health - enrofloxacinum - tabletti - 100 mg - enrofloksasiini
zobuxa vet 150 mg tabletti
novartis healthcare a/s animal health - enrofloxacinum - tabletti - 150 mg - enrofloksasiini
icandra (previously vildagliptin / metformin hydrochloride novartis)
novartis europharm limited - vildagliptiini, metformiinihydrokloridia - diabetes mellitus, tyyppi 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - icandra is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 ja 5. 1 käytettävissä olevista tiedoista eri yhdistelmistä).
ilcocillin vet 300 mg/ml injektioneste
novartis animal health inc. - benzylpenicillinum procainum - injektioneste - 300 mg/ml - prokaiinipenisilliini
clynav injektioneste, liuos
novartis animal health uk ltd - puhdistettu plasmidi-dna - injektioneste, liuos
imprida
novartis europharm ltd - valsartan, amlodipine (as amlodipine besilate) - verenpainetauti - reniini-angiotensiinijärjestelmään vaikuttavat aineet - essentiaalisen hypertension hoito. imprida on tarkoitettu potilaille, joiden verenpaine ei laske riittävästi yksinomaan amlodipiinilla tai valsartaanilla.
enviage
novartis europharm ltd. - aliskireeni - verenpainetauti - reniini-angiotensiinijärjestelmään vaikuttavat aineet - essentiaalisen hypertension hoito.